IL6 and COVID-19: More notably, we observed that the elevation of IL-6 before the aggravated pulmonary lesions in the majority of COVID-19 patients; thus, we speculated that IL-6 might serve as a driving factor for pulmonary pathogenesis during SARS-CoV-2 infection.